
DIAGNOS INC.
ADK
![]() |
|
0.64CAD | --.--% |
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
Net sales1 | 0,56 | 0,63 | 1,80 | 1,29 | 0,33 | 0,33 |
EBITDA1 | -2,63 | -2,52 | -1,81 | -2,49 | -2,74 | -2,71 |
Operating profit (EBIT)1 | -2,67 | -2,59 | -1,99 | -2,71 | -2,93 | -2,80 |
Operating Margin | -473% | -413% | -110% | -210% | -897% | -844% |
Pre-Tax Profit (EBT)1 | -2,83 | -3,04 | -2,94 | -3,96 | -3,90 | -3,38 |
Net income1 | -2,83 | -3,19 | -2,93 | -2,90 | -3,84 | -3,38 |
Net margin | -501% | -509% | -162% | -224% | -1 176% | -1 020% |
EPS2 | -0,29 | -0,30 | -0,24 | -0,17 | -0,20 | -0,08 |
Dividend per Share | - | - | - | - | - | - |
Last update | 06/30/2016 | 08/28/2017 | 07/27/2018 | 06/27/2019 | 06/05/2020 | 06/05/2020 |
1 CAD in Million 2 CAD |
Finances - Leverage
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
Net Debt1 | 0,54 | 2,94 | 3,08 | 4,35 | 4,87 | - |
Net Cash position1 | - | - | - | - | - | 1,51 |
Leverage (Debt / EBITDA) | -0,20x | -1,17x | -1,70x | -1,75x | -1,78x | 0,56x |
Free Cash Flow1 | -1,97 | -1,74 | -1,73 | -2,11 | -1,79 | -2,28 |
ROE (Net Profit / Equities) | -4 632% | 215% | 107% | 115% | 88,1% | 207% |
Shareholders' equity1 | 0,06 | -1,48 | -2,75 | -2,52 | -4,36 | -1,63 |
ROA (Net Profit / Asset) | -121% | -133% | -96,3% | -120% | -134% | -96,0% |
Assets1 | 2,33 | 2,40 | 3,04 | 2,42 | 2,86 | 3,52 |
Book Value Per Share2 | -0,02 | -0,25 | -0,20 | -0,21 | -0,24 | 0,03 |
Cash Flow per Share2 | 0,03 | 0,04 | 0,01 | 0,01 | 0,01 | 0,01 |
Capex1 | 0,02 | 0,18 | 0,23 | 0,27 | 0,04 | 0,02 |
Capex / Sales | 3,64% | 28,2% | 12,9% | 21,0% | 13,0% | 4,56% |
Last update | 06/30/2016 | 08/28/2017 | 07/27/2018 | 06/27/2019 | 06/05/2020 | 06/05/2020 |
1 CAD in Million 2 CAD |
Balance Sheet Analysis
Price Earning Ratio
EPS & Dividend